About Ketabon
Ketabon is a company based in Munchen (Germany) founded in 2022. It operates as a B2B. Ketabon operates in a competitive market with competitors including GH Research, Lykos and Small Pharma, among others.
- Headquarter Munchen, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ketabon
Detailed funding history for Ketabon
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ketabon
Investment portfolio details for Ketabon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ketabon
Detailed financials for Ketabon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ketabon Comparisons
Peer comparison for Ketabon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ketabon
Ketabon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GH Research, Lykos and Small Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for mental disease management are developed using 5-MeO-DMT formulations.
|
|
| Locked | Locked | Locked |
Developer of therapeutics to treat mental health conditions
|
|
| Locked | Locked | Locked |
Psychedelic-based therapeutics for mental health conditions are developed.
|
Detailed competitors of Ketabon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ketabon
Complete news archive for Ketabon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ketabon
Ketabon was founded in 2022.
Ketabon is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Ketabon operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, advancing biotech innovations, and supporting mental health solutions. Develops innovative therapeutics for treatment-resistant depression. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Ketabon's top competitors include GH Research, Lykos and Small Pharma.